135 related articles for article (PubMed ID: 33385852)
21. Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents.
Kilic-Kurt Z; Ozmen N; Bakar-Ates F
Bioorg Chem; 2020 Aug; 101():104028. PubMed ID: 32645482
[TBL] [Abstract][Full Text] [Related]
22. Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy.
Li ZH; Zhang J; Liu XQ; Geng PF; Ma JL; Wang B; Zhao TQ; Zhao B; Wei HM; Wang C; Fu DJ; Yu B; Liu HM
Eur J Med Chem; 2017 Jul; 135():204-212. PubMed ID: 28456031
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antiproliferative activity of thiazolo[5,4-d]pyrimidine derivatives through the atom replacement strategy.
Li ZH; Liu XQ; Geng PF; Zhang J; Ma JL; Wang B; Zhao TQ; Zhao B; Zhang XH; Yu B; Liu HM
Eur J Med Chem; 2017 Sep; 138():1034-1041. PubMed ID: 28759876
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors.
Wang R; Yu S; Zhao X; Chen Y; Yang B; Wu T; Hao C; Zhao D; Cheng M
Eur J Med Chem; 2020 Feb; 188():112024. PubMed ID: 31923858
[TBL] [Abstract][Full Text] [Related]
27. Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors.
Mahnashi M; Alshahrani MM; Al Ali A; Asiri A; Abou-Salim MA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2203879. PubMed ID: 37080777
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR
Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH
Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185
[TBL] [Abstract][Full Text] [Related]
29. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
30. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.
Lauria A; Patella C; Abbate I; Martorana A; Almerico AM
Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807
[TBL] [Abstract][Full Text] [Related]
31. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
[TBL] [Abstract][Full Text] [Related]
32. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381
[TBL] [Abstract][Full Text] [Related]
33. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
[TBL] [Abstract][Full Text] [Related]
35. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis and Anti-Proliferative Activities of 2,6-Substituted Thieno[3,2-d]pyrimidine Derivatives Containing Electrophilic Warheads.
Zhang Q; Hu Z; Shen Q; Chen Y; Lu W
Molecules; 2017 May; 22(5):. PubMed ID: 28498316
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents.
Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y
Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of novel β-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway.
Wang Y; Wu C; Zhang Q; Shan Y; Gu W; Wang S
Bioorg Chem; 2019 Mar; 84():468-477. PubMed ID: 30576910
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and suppress cell migration.
Liu YM; Li Y; Xiao J; Zhang QZ; Song JX
J Asian Nat Prod Res; 2020 Jun; 22(6):547-561. PubMed ID: 30938545
[TBL] [Abstract][Full Text] [Related]
40. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
